Diabetes & Checkpoint Inhibitors

Immune Checkpoint Inhibitors are novel treatments for cancer, but their use has been associated with increased risk of developing type I diabetes. Discover the latest research here.

August 28, 2020
Open Access

Vitamin D Supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of Children with Type 1 Diabetes

The Journal of Clinical Endocrinology and Metabolism
Silvia SavastioFlavia Prodam
September 23, 2020
Comment / Editorial
Open Access

Biological activity versus physiological function of proinsulin C-peptide

Cellular and Molecular Life Sciences : CMLS
Michael Landreh, Hans Jörnvall
August 11, 2020
Open Access

Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus

Journal of Immunology Research
Mohamed A El-MokhtarAmira M Shalaby
August 23, 2020
Review
Open Access

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients-Literature Review

Cancers
Marta DudzińskaAgnieszka Zwolak
September 15, 2020
Open Access

Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival

Science Advances
María M CoronelAndrés J García
September 8, 2020

Primary and Ipilimumab-induced Hypophysitis: A Single-center Case Series

Endocrine Research
Paul Atkins, Ehud Ur
September 4, 2020

Biomarkers of inflammation and glomerular filtration rate in individuals with recent-onset type 1 and type 2 diabetes

The Journal of Clinical Endocrinology and Metabolism
Haifa MaalmiMichael Roden
August 26, 2020

Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019)

Expert Opinion on Therapeutic Patents
Carlos Roca, Nuria E Campillo
August 5, 2020

Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes

Nature Immunology
Natalie M EdnerLucy S K Walker
August 22, 2020
Review
Open Access

Secondary causes of inflammatory bowel diseases

World Journal of Gastroenterology : WJG
Yezaz A GhouriBo Shen
September 22, 2020

Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes

Journal of Autoimmunity
Angela LombardiYaron Tomer
September 2, 2020
Review

Metformin and cancer immunity

Acta Pharmacologica Sinica
Ruixia MaYaguang Xi
August 30, 2020

Splenic 18 F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Gynecologic Oncology
Emiel A De JaeghereKatrien Vandecasteele
August 6, 2020
Case Report
Open Access

Pembrolizumab: An Immunotherapeutic Agent Causing Endocrinopathies

Curēus
Abdul ChaudryJonaid Aslam
September 18, 2020
Open Access

Axenic Caenorhabditis elegans antigen protects against development of type-1 diabetes in NOD mice

Journal of Translational Autoimmunity
Belinda M Jackson-ThompsonEdward Mitre
September 5, 2020

Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint Inhibitors

Annual Review of Medicine
Zoe QuandtMark S Anderson

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved
/feed-previews/diabetes-checkpoint-inhibitors/3d58dc30-e623-4700-8347-a880f8103e15